Avi grow up? A neurotic Jewish man in his 50's? About as likely as a tiger changing it's stripes. As far as shareholders showing him the door, the board of directors are his people. You would have to take legal action to acquire the shareholder list and petition them to vote on a different slate.
I have been hearing about potential for 5 years. Potential in the hands of a money grubbing sociopath never gets realized. It's just one tease after another on the road to Avi's self enrichment. If I wanna get teased I'll go to a gentlemen's club. At least I get somethin to play with while I'm dreamin. The shmuck is incapable of telling the truth to shareholders, never mind what he tells to the people he has to work with every day. He wanted the GSIT cash hoard, he could care less about the business combination or the GSIT employers or shareholders. I got out of this stock last year at $2.25 after sitting on it for 4 years of promises of GAAP profits and how TFOP will revolutionize the 4G buildout, and I consider myself blessed. I wouldn't own stock in a company run by Avi Katz at any price.. God bless ya and keep ya aggies!
Aggressive buying on 9/08 and bid up when the stock was down. Here's the deal- estimated market for a safe, non-addictive ADHD/OCD drug est $2bil annually. This would instantly become first line of treatment in adults and off-label w kids and other related focus, manic disorders. Psych drugs are tricky in trials. Most of the people who are depressed, bypolar, schizophrenic, anxious, OCD, ADHD tend to do better in structured clinical situations w caregivers even on placebos. so it's not so easy to prove quantum benefits in the randomized drug group, but over time and well planned trials it IS definitely provable, and there is no question in my mind MDX works well on most people- don't ask me how I know. When you factor in that metadoxine, pyridoxine are already approved/ GRAS by the FDA, ADHD's drug, if it can show even modest benefit. will be approved and the company could be taken out by one of the big pharmas for oh I don't know, somewhere north of $40. This may well be a legitimate blockbuster. God bless ya'll
5KBOED still a viable target. Takes time. Lotta work, virgin territory New Zealand, but you can't drive there. Infrastructure buildout progressing nicely. You can't blame the management for talking up the business while they're growing it, and they are, even if the line is not as straight as some investors may have first envisioned. I think you'll make a nice return on your higher basis original investment over time, Anybody who buys the stock down here has nothing but double upside in their future. This is quite a story in my opinion and it has to be widely told.
I was a shareholder of GIG for a long time- too long. Avi Katz is a #$%$. He lines his pockets with investor's money. The company has never made a GAAP dime, he has never made a dime for GIG shareholders. If you had purchased GIG 4 yrs ago you would be down 50% bleeding a little more every year like a stuck pig. Meanwhile Avi has circumvented fiduciary interest securities laws and funneled $millions into his pocket w cash awards and free stock options. It is clear to me why he wants to merge. If he tries to pull any more cash out of GigOptix, he's may be thinking someone out there might put a bullet in his head. He wants to steal the GSIT cash hoard.
The quarterly report was good- nice YOY increase in production and earnings, projectable expansion of low risk high cash flow drilling program and clear guidance on potentially transformational fracking business. You have high leverage right here right now and you usually don't get that unaccompanied by LT debt, but the company has none. You weekly whiners all apparently bought the stock when it was higher. That's on you. If you were smart, you'd average down right now. Just because you weren't smart in your initial entry point, doesn't mean you can't be smart now.
The U.S. is full of the illogical and ignorant people w Ameritrade accounts and money to lose. It's a casino mentality masqerading as "investing" Kinda sad...
That's where it settled when the FDA ordered a hold on the clinical trials. Nothing has really changed. If any of this stuff does get sent to Africa, it's going to be sent for free, nobody is going to pay for it, and it will not be possible to draw any conclusions on it's efficacy/ side effects, because only a few people would get it and the clinical setting does not exist. Anecdotal is someone lives, tragic if someone dies. It's a lose, lose for Tekmira. The ZMap is less problematic in terms of side effects, and production is now being accelerated, according to Zeitlin. The preventive vaccine should be available sometime in 2015 anyway, and all this may be moot.
Am I dreaming, can't tell sometimes. This is the most volume we've seen in a year!
Cytokines drive COX and LOX enzymes to activate immune responses. They are a necessary part of mammalian response to injury and infection. Many people with poor diet, poor genes, or long term exposure to environmental stresses produce cytokines in excess- this is a characteristic of autoimmune diseases like RA, psoriasis, Crohn's, Lupus, even asthma. High cytokine production in Ebola patients would be considered desirable if carrying the virus whether by innoculation or incidental exposure. In my opinion, and I have a science as well as business background the Tekmira drug is going to get fast tracked with a special protocol allowing the NIH and the FDA to collaborate directly with the team at the company to accelerate development. No question in my mind about this.... Couldn't tell you what it means for the stock. Probably keep going up until it's proven not to work and that won't happen any time soon, if ever. I think every nation would have to stockpile a drug effective against Ebola. You guys do the math.......
the results will be devastating. There is a genetic immune response that has been conferred over time to a significant percentage of native Africans. The rest of us are immunologically completely naive. I worked in Belize in 1995 and contracted Dengue- a similarly hemorrhagic virus. The locals weren't worried about it. I almost died, lost 40 pounds, my organs were failing and I was given 6 months to live. I had been in perfect health until it happened and made it through with the help of an experimental drug made available to me at the Baylor University Medical Center. But I still carry the virus, and I have had a host of medical problems since the original infection. They need to get out it front of this thing NOW!
Whether or not this particular outbreak goes cross-border pandemic- and it certainly appears to be, a vaccine to protect against Ebola and to save the newly infected has to be among the top 3 medical pursuits on the planet- along with cures for cancer(s) and Alzheimer's, Tekmira is the only company with a vaccine that protects against Ebola in primates. As such, development and commercialization will be accelerated. I can pretty much guarantee you the woman that is head of the FDA will be meetings next week to figure out how to do this. Buy it and pray.
The hottest sector in biotech is diagnostic equipment that makes disease screening cheaper, faster, safer and more accessible to more would be patients. APPY does all this. According to my sources, the product is in the process of being approved by the FDA, the only remaining detail is instructions and application guide. I don't have any inside information on timing, but my best guess is very soon- possibly an announcement could come concurrent with the presentation on the 9th.
Similar, possibly more advanced immunotherapy platform out of Raleigh Durham. Very thin, catalysts approaching. Could go way big on KITE PR. Gunn says pick it up, he's 93% on double picks.......